Methods for modulating T cell survival by modulating BCL-XL protein level

Details for Australian Patent Application No. 2007202459 (hide)

Owner Arch Development Corporation United States of America, represented by the Secretary of the Navy

Inventors June, Carl H.; Thompson, Craig B.

Agent FB Rice

Pub. Number AU-A-2007202459

Parent 2003254769

Filing date 29 May 2007

Wipo publication date 21 June 2007

International Classifications

C12N 15/12 (2006.01) Mutation or genetic engineering - Genes encoding animal proteins

A61K 48/00 (2006.01) Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases

Event Publications

14 June 2007 Complete Application Filed

21 June 2007 Application Open to Public Inspection

  Published as AU-A-2007202459

1 December 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007202460-A gate

2007202458-Micro miniature air gap inspection crawler